Literature DB >> 2920904

The prevention of an acute rise in intraocular pressure following Q-switched Nd:YAG laser iridotomy with clonidine.

Y Kitazawa1, K Sugiyama, T Taniguchi.   

Abstract

We evaluated the ability of topical clonidine to suppress an acute rise in postoperative intraocular pressure (IOP) following Nd:YAG laser iridotomy. A total of 36 eyes (29 patients) with chronic primary angle-closure glaucoma underwent Q-switched Nd:YAG laser iridotomy: 18 eyes were treated topically with 0.5% clonidine ophthalmic solution prior to and immediately following the procedure, and a control group of 18 eyes underwent Nd:YAG laser iridotomy without topical clonidine. The control group was selected to match the clonidine-treated group in terms of preoperative IOP, the extent of peripheral anterior synechia, and the total amount of laser energy delivered. None of the clonidine-treated eyes experienced an IOP rise greater than 4 mm Hg over baseline, whereas 4 of the nontreated eyes (22.2%) developed an IOP rise greater than 10 mm Hg. The mean IOPs were significantly lower during the first 4 h postsurgery in the clonidine-treated eyes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920904     DOI: 10.1007/BF02169817

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  Increased intraocular pressure following neodymium-YAG laser iridectomy.

Authors:  J C Henry; T Krupin; J Schultz; M Wax
Journal:  Arch Ophthalmol       Date:  1986-02

2.  Neodymium-YAG laser iridectomies in glaucoma associated with closed or occludable angles.

Authors:  L W Schwartz; M R Moster; G L Spaeth; R P Wilson; E Poryzees
Journal:  Am J Ophthalmol       Date:  1986-07-15       Impact factor: 5.258

3.  A new goniolens for corneal indentation gonioscopy.

Authors:  Y Nakamura; Y Kitazawa
Journal:  Acta Ophthalmol (Copenh)       Date:  1971

4.  Q-switched neodymium-YAG laser iridotomy. A field trial with a portable laser system.

Authors:  A L Robin; S Arkell; S M Gilbert; A A Goossens; R P Werner; O M Korshin
Journal:  Arch Ophthalmol       Date:  1986-04

5.  Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty.

Authors:  A L Robin; I P Pollack; B House; C Enger
Journal:  Arch Ophthalmol       Date:  1987-05

6.  A comparison of neodymium: YAG and argon laser iridotomies.

Authors:  A L Robin; I P Pollack
Journal:  Ophthalmology       Date:  1984-09       Impact factor: 12.079

7.  Argon laser iridotomy and surgical iridectomy in treatment of primary angle-closure glaucoma.

Authors:  F J Go; Y Akiba; T Yamamoto; Y Kitazawa
Journal:  Jpn J Ophthalmol       Date:  1984       Impact factor: 2.447

8.  The effect of topical clonidine on intraocular pressure.

Authors:  E Hodapp; A E Kolker; M A Kass; I Goldberg; B Becker; M Gordon
Journal:  Arch Ophthalmol       Date:  1981-07

9.  The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers.

Authors:  D A Abrams; A L Robin; I P Pollack; J M deFaller; L DeSantis
Journal:  Arch Ophthalmol       Date:  1987-09

10.  Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy.

Authors:  A L Robin; I P Pollack; J M deFaller
Journal:  Arch Ophthalmol       Date:  1987-09
View more
  5 in total

Review 1.  A risk-benefit assessment of drugs used in the management of glaucoma.

Authors:  T Taniguchi; Y Kitazawa
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

2.  Effect of norfloxacin and clonidine on human trabecular meshwork cells in vitro.

Authors:  Q Wang; H Wei; Z Fan; Y Lu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

Review 3.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

4.  Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.

Authors:  N Yüksel; C Güler; Y Caglar; O Elibol
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

5.  Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.

Authors:  E Gramer; S Busche; A Kampik; D Parsons
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.